QUOTE AND NEWS
FiercePharma  Aug 17  Comment 
Novo Nordisk, fighting competition to its blockbuster Victoza, just posted data on a follow-up drug that gives it an edge over archrival Trulicity. That Lilly med has stolen share from Victoza, but the new head-to-head results, coupled with CV...
Wall Street Journal  Aug 15  Comment 
For almost a century, pharmaceutical giant Novo Nordisk rolled out new versions of its core product at higher prices. Then suddenly, governments and insurers decided the older, less expensive versions were good enough.
Motley Fool  Aug 14  Comment 
A solid-enough second quarter from the diabetes specialist boosts investors' confidence in a turnaround.
Clusterstock  Aug 10  Comment 
Novo Nordisk CEO Lars Fruergaard Jorgensen knows that his company is facing pressure in the US over the rising price of the diabetes medication insulin. Jorgensen told Business Insider that he expects that people who have trouble paying for...
Motley Fool  Aug 9  Comment 
These stocks rose on a down day for Wall Street. Find out why.
FiercePharma  Aug 9  Comment 
Novo Nordisk, like its rival drugmakers in diabetes, is still grappling with the pricing pressure that’s assaulted the business for a couple of years. That’s the bad news. The good? Pricing isn’t the be-all of growth. It’s portfolio.





You may also be interested in articles related to Novo Nordisk A/S (NVO):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki